AU
Aurobindo
AUROPHARMA.NS·NSEHyderabad INFounded 198622,000 employees
Mid CappharmaPublicInfectious DiseaseOncology
Platform: Generic API
Market Cap
$6B
All Drugs
4
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (AUROPHARMA.NS)
Loading AUROPHARMA.NS stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Nidacilimab | AUR-8315 | Approved | 1 | JAK2 | PsoriasisADPKD | ||
| AUR-9187 | AUR-9187 | Phase 2 | 2 | PD-L1 | HSNB | ||
| AUR-7289 | AUR-7289 | Preclinical | 2 | SHP2 | Pancreatic CaSchizophrenia | ||
| Datotapinarof | AUR-8122 | Phase 1 | 1 | AHR | Thymoma |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Aurobindo trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)